SMTL ID : 8tsd.1

Human PI3K p85alpha/p110alpha bound to RLY-2608

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

hetero-1-1-mer

Ligands

1 x XUZ: N-{(3R,6M)-3-(2-chloro-5-fluorophenyl)-6-[(4S)-5-cyano[1,2,4]triazolo[1,5-a]pyridin-6-yl]-1-oxo-2,3-dihydro-1H-isoindol-4-yl}-3-fluoro-5-(trifluoromethyl)benzamide(Non-covalent)

XUZ.1: 18 residues within 4Å: Chain A: Q.819, L.822, T.823, I.920, L.921, G.922, I.923, F.947, L.948, K.951, V.962, F.1012, E.1022, L.1023, D.1028, I.1029, Y.1031, I.1032 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.962, A:Y.1031, A:Y.1031, A:Y.1031, A:I.1032 Hydrogen bonds: A:L.921, A:D.1028 pi-Stacking: A:F.1012, A:Y.1031 pi-Cation interactions: A:K.951 Halogen bonds: A:Q.819, A:I.920, A:E.1022

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Varkaris, A. et al., Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3K alpha Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discov (2024)

Release Date

2023-11-22

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A
Phosphatidylinositol 3-kinase regulatory subunit alpha: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Phosphatidylinositol 3-kinase regulatory subunit alpha

Related Entries With Identical Sequence